Related Experiment Video
Updated: May 22, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional
Yue Jia1,2,3, Jiaojiao Liu1,2,3, Yichen Lou1,2,3
1Department of First Clinical Medicine, Shanxi Medical University, Taiyuan, China.
Abstract:
Laryngeal squamous cell carcinoma (LSCC) exhibits aggressive growth, frequent recurrence, and a notable resistance to existing treatments. Building upon prior discoveries that identified junctional adhesion molecule 3 (JAM3) as a critical tumor suppressor in LSCC, this study delves into the transcriptional regulation by upstream stimulatory factor 1 (USF1) and its implications for LSCC pathogenesis. Employing dual-luciferase assays and chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR), we confirmed USF1's direct binding to the E-box within the JAM3 promoter, thereby enhancing JAM3 expression in AMC-HN-8 and FD-LSC-1 cells. Complementary in vitro assays and in vivo experiments corroborated that USF1 overexpression markedly reduces tumor aggressiveness, linked to heightened JAM3 activity. Further analysis, including Western blot and immunohistochemistry of xenograft tumor tissues, revealed that increased JAM3, stimulated by USF1, activates the Hippo signaling pathway, underscoring its role in tumor suppression. These findings position USF1 and JAM3 as pivotal elements in the molecular framework of LSCC, suggesting their potential as targets for therapeutic intervention.
Insights
Upstream stimulatory factor 1 (USF1) enhances junctional adhesion molecule 3 (JAM3) expression, suppressing laryngeal squamous cell carcinoma (LSCC) growth. This USF1-JAM3 axis activates the Hippo pathway, offering new therapeutic targets for LSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Laryngeal squamous cell carcinoma (LSCC) is aggressive and treatment-resistant.
- Junctional adhesion molecule 3 (JAM3) is a known tumor suppressor in LSCC.
- The upstream regulators of JAM3 in LSCC remain largely uncharacterized.
Purpose of the Study:
- To investigate the transcriptional regulation of JAM3 by upstream stimulatory factor 1 (USF1) in LSCC.
- To elucidate the role of the USF1-JAM3 axis in LSCC pathogenesis and tumor suppression.
- To explore the therapeutic potential of targeting USF1 and JAM3 in LSCC.
Main Methods:
- Dual-luciferase assays and ChIP-qPCR to confirm USF1 binding to the JAM3 promoter.
- In vitro and in vivo experiments to assess the impact of USF1 overexpression on LSCC aggressiveness.
- Western blot and immunohistochemistry to analyze Hippo signaling pathway activation.
Main Results:
- USF1 directly binds to the JAM3 promoter, enhancing JAM3 expression in LSCC cells.
- USF1 overexpression significantly reduces LSCC tumor aggressiveness, correlating with increased JAM3 activity.
- USF1-induced JAM3 activation triggers the Hippo signaling pathway, contributing to tumor suppression.
Conclusions:
- USF1 acts as a transcriptional activator of JAM3 in LSCC.
- The USF1-JAM3 interaction suppresses LSCC progression via the Hippo signaling pathway.
- USF1 and JAM3 represent promising therapeutic targets for laryngeal squamous cell carcinoma.
More Related Videos
Related Concept Videos
Master Transcription Regulators
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
TGF - β Signaling Pathway
Transcription Factors
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

